Healthineers launches rapid coronavirus antigen test, sees tight supply

By Ludwig Burger

FRANKFURT (Reuters) – Siemens Healthineers on Wednesday announced the launch of a rapid antigen test kit in Europe to detect coronavirus infections, but warned that the industry may struggle to meet a surge in demand.

The German group, whose rivals in diagnostics include Roche, Abbott and Becton Dickinson , said its test cassette did not require lab processing and would deliver results in 15 minutes, but that the required nasal swabs would have to be taken by healthcare professionals.

PCR (polymerase chain reaction) tests, which scan genetic code for the markers of a virus, are the gold standard for finding infections but are two to three times more expensive than antigen tests and require processing in a lab.

Antigen tests, which look for proteins found on the surface of the virus, cost about 4-5 euros ($5-$6) each, but miss a few percent of the infections that PCR tests would have caught.

Currently, slightly more than 1 million standard PCR tests are performed in Germany every week.

However, public health systems around the world are eager to provide quick diagnostic tools, and test more widely, to help locate hotspots of the pandemic.

Germany’s health ministry last week said it had secured 9 million antigen tests.

The regional state of Bavaria followed up this week with an order for 10 million antigen tests, saying it had options to purchase from Healthineers, Roche and Abbott. It did not give a timeframe for their use.

“The volumes that are being circulated globally are probably at the limits of what manufacturers can currently supply,” a Healthineers spokesman said.

“We are currently in talks with various governments over possible supply orders.”

The United States and Canada are also buying millions of tests, as is Italy, whose recent tender for 5 million tests attracted offers from 35 companies.

Healthineers is also planning to seek approval for a launch in the United States. ($1 = 0.8501 euros)

(Additional reporting by Caroline Copley; Editing by Riham Alkousaa and Editing by Kevin Liffey)

Source Article

Read More →

Breast cancer survivor urges women to get regular screenings and mammograms, thanks local non-profit ‘The Rose’

The first time Ediana Quijada found a lump in her breast, she was laughed off and told “it was happening because of her period and nothing to worry about.”

It was far from nothing. After a six-year battle with metastatic breast cancer, the cheerful Houston native is happy to share her story with other young women, advising regular breast exams, early detection having made a key difference in many cases.

In the fall of 2012, 29-year-old Ediana was finishing her construction management internship at the University of Houston.

The internship did not offer health insurance but UH hosts free mammography screenings in October in honor of Breast Cancer Awareness month. However, when she told the nurses about her lump, they assured her, with a cursory glance, that she was too young to worry about cancer. She was sent away without a mammogram.

Reassured and a little abashed about being paranoid, she busied herself with assignments as the stresses of the semester took over. The second of four siblings (two sisters, one little brother), Ediana said she had no reason to suspect the worst because there was no history of cancer in her family.

But the lump wouldn’t stay quiet.


“I started feeling that the little lump was getting bigger and bigger,” Ediana said. “I could measure it; it was an inch now. Or is it in my head? Then I would calculate, my period must be coming, that’s why the lump’s getting big … and my breast is turning pink.”

A visit with her mother’s doctor in December confirmed the devastating news — a large mass in her breast. Could be a tumor. Clearly, the cancer had made good use of the two-month delay.

“I didn’t have insurance, so my mother took me to a walk-in clinic,” Eidana said. “The doctor said, ‘oh my God, why didn’t you come before?’”

A few hours and one $100-ultrasound later, she was advised to do a biopsy.

“The biopsy cost over $2,000, I thought ‘I can’t do that right now,’ and he (the doctor) referred me to The Rose,” Ediana said.

That first encounter with The Rose marked the beginning of Ediana’s long, painful but ultimately successful battle with breast cancer. A Houston-based nonprofit group, The Rose provides breast cancer screenings and treatment regardless of patients’ ability to pay. They began Ediana’s treatment by conducting another ultrasound, this one costing only $10.

A little monster inside your breast.

Ediana was paired with a patient navigator who helped her through the system and set up her appointments.

“It turns out I was Stage 3, Type C, which is borderline Stage 4,” said Ediana. “Very aggressive and very bad. They said, ‘it looks like you have a little monster inside’.”

Given the tumor’s massive size, treatment had to begin immediately. When three painful rounds of chemo (each lasting around eight months), one round of radiation and one surgery failed to eliminate the cancer, her doctors put Ediana on an–at the time–experimental drug called T-DM1.

“This

Read More →

Here’s what’s happening Wednesday with COVID-19 in the Chicago area

Chicago on Tuesday added neighboring Indiana to its emergency travel order that requires travelers returning to the city from there to stay inside for two weeks because of high COVID-19 case counts. The Hoosier state’s inclusion on Chicago’s self-quarantine list was expected.



a man standing in front of a pool: Shelley Gavin, 55, gets a free COVID-19 test provided by Community Organized Relief Effort at I Grow Chicago in West Englewood on Aug. 31, 2020.


© Zbigniew Bzdak / Chicago Tribune/Chicago Tribune/TNS
Shelley Gavin, 55, gets a free COVID-19 test provided by Community Organized Relief Effort at I Grow Chicago in West Englewood on Aug. 31, 2020.

Starting Friday, people traveling into Chicago from Indiana, including Chicagoans who have traveled to Illinois’ eastern neighbor, to will be expected to quarantine themselves for 14 days. Violators can face a fine, though the city has taken few steps to enforce the rules and there are exceptions for essential workers.



a close up of a toy: A worker packages a COVID-19 test swab from a client at Prism Heath Lab, 2322 W. Peterson Ave., in Chicago, on Aug. 6, 2020.


© Jose M. Osorio / Chicago Tribune/Chicago Tribune/TNS
A worker packages a COVID-19 test swab from a client at Prism Heath Lab, 2322 W. Peterson Ave., in Chicago, on Aug. 6, 2020.

The move came as Illinois health officials announced 2,851 newly confirmed cases of COVID-19 and 29 additional deaths, pushing the state’s death toll past 9,000.



a person sitting in a car: Workers conduct drive-thru COVID-19 testing at Swedish Covenant Hospital on Oct. 13, 2020, in the Ravenswood neighborhood of Chicago.


© Erin Hooley / Chicago Tribune/Chicago Tribune/TNS
Workers conduct drive-thru COVID-19 testing at Swedish Covenant Hospital on Oct. 13, 2020, in the Ravenswood neighborhood of Chicago.

It was the seventh day in a row with more than 2,600 cases. That brings the state total to 324,743 confirmed cases and 9,026 deaths. The seven-day statewide positivity rate is 4.5% for the week ending Oct. 12.

Loading...

Load Error

COVID-19 in Illinois by the numbers: Here’s a daily update on key metrics in your area

COVID-19 cases in Illinois by ZIP code: Search for your neighborhood

Chicago’s travel quarantine list: Here’s what you need to know to avoid a large fine

Illinois coronavirus graphs: The latest data on deaths, confirmed cases, tests and more

Here’s what’s happening Wednesday with COVID-19 in the Chicago area and Illinois:

6:55 a.m.: Challenges to Pritzker’s COVID-19 restrictions back in court

After months of maneuvering, attorneys will be in court in Sangamon County Wednesday arguing over Gov. JB Pritzker’s powers to impose controls to curtail the spread of the coronavirus.

The hearing involves multiple cases filed by attorney Thomas DeVore on behalf of clients in six counties who contend that the coronavirus pandemic is not a public health emergency under the definition of Illinois law.



a person wearing a costume: Workers prepare for a drive-thru COVID-19 testing participant at Swedish Covenant Hospital on Oct. 13, 2020, in the Ravenswood neighborhood of Chicago.


© Erin Hooley / Chicago Tribune/Chicago Tribune/TNS
Workers prepare for a drive-thru COVID-19 testing participant at Swedish Covenant Hospital on Oct. 13, 2020, in the Ravenswood neighborhood of Chicago.

Because of that, the lawsuits argue that Pritzker doesn’t have the authority impose restrictions like limit on businesses in order to control the spread of COVID-19.

The essentially identical lawsuits were originally filed in Edgar, Bond, Richland, Clinton, and Sangamon counties. In each case, plaintiffs want the court to declare a public health emergency does not exist and that Pritzker be barred from exercising powers under the Emergency Management Act in those counties.



a person sitting in a parking lot: A warning sign alerts passersby as vehicles are lined up at a COVID-19 testing site at Saucedo Scholastic Academy on Oct. 13, 2020, in Chicago.


© John J. Kim / Chicago Tribune/Chicago Tribune/TNS
A warning

Read More →

Khloe Kardashian’s fitness schedule kept her ‘sane’

Khloe Kardashian’s fitness schedule kept her “sane” during lockdown.



Khloe Kardashian standing in front of a brick wall


© Bang Showbiz
Khloe Kardashian

The ‘Keeping Up With The Kardashians’ star admits there have been some “crazy times” in the world because of the coronavirus pandemic but she has turned to exercise to keep her going and keep her mental state positive too.

Gallery: Bachelorettes Unite! 13 Alumni Reveal What They’ve Learned on Their Journeys to Finding Love (People)

Explaining about her fitness regime, she said: “I definitely think because of my fitness journey and already having such a regimented schedule when it comes to working out, it kind of kept me sane during these crazy times. I had to learn to adapt by doing mommy-daughter workouts. [True] is obviously not working out, but it’s things like me putting her in a wagon and sprinting up a hill. I belted a wagon to my waist because I don’t have any help. We’re all just trying to figure it out.”

And the 36-year-old reality television star wants to set a good example for her daughter True when it comes to her exercise regime and she hopes her daughter will be “active and take care of herself” like her mom.

Speaking to Refinery29, she added of her lifestyle: “I want to show my daughter, by example, that there are healthy ways to be active every day.

“You don’t have to be so rigid in the gym. I like to work out early, it just sets the tone for the rest of my day, it makes me want to eat better and be active and healthy. By her seeing me like this, I hope she’s active and takes care of herself.”

Continue Reading

Source Article

Read More →

Taysha Gene Therapies Receives Rare Pediatric Disease Designation and Orphan Drug Designation for TSHA-102 as a Treatment for Rett Syndrome

Program leverages novel miRARE platform technology used to control transgene expression on a cellular basis

TSHA-102 anticipated to submit Investigational New Drug application in 2021

Taysha Gene Therapies Inc. (Nasdaq: TSHA), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations, today announced that it has received rare pediatric disease designation and orphan drug designation from the U.S. Food and Drug Administration (FDA) for TSHA-102, an AAV9-based gene therapy in development for the treatment of Rett syndrome. Taysha anticipates that it will submit an Investigational New Drug (IND) application for TSHA-102 to the FDA in 2021.

Rett syndrome is one of the most common genetic causes of severe intellectual disability worldwide, with a prevalence of over 25,000 cases in the U.S. and European Union (EU). It is an X-linked disease that primarily occurs in females, but it can be seen very rarely in males. It is usually recognized in children between six to 18 months of age as they begin to miss developmental milestones or lose abilities they had developed. Individuals with Rett syndrome also show symptoms that include loss of speech, loss of purposeful use of hands, loss of mobility, seizures, cardiac impairments, breathing issues and sleep disturbances.

“Patients with Rett syndrome are currently managed with symptomatic treatments as there are no therapies approved to treat the underlying cause of disease,” said Berge Minassian, M.D., Chief Medical Advisor of Taysha and Chief of Pediatric Neurology at the University of Texas Southwestern Medical Center (UT Southwestern). Dr. Minassian is credited with describing the CNS isoform of the MECP2 gene which is responsible for neuronal and synaptic function throughout the brain. “Gene therapy offers a potentially curative option for patients suffering with Rett syndrome.”

Rett syndrome is caused by mutations in the MECP2 gene. TSHA-102 is designed to deliver a healthy version of the MECP2 gene as well as the miRNA-Responsive Auto-Regulatory Element, miRARE, platform technology to control the level of MECP2 expression. “TSHA-102 represents an important step forward in the field of gene therapy, where we are leveraging a novel regulatory platform called miRARE to prevent the overexpression of MECP2,” said Steven Gray, Ph.D., Chief Scientific Advisor of Taysha and Associate Professor in the Department of Pediatrics at UT Southwestern. “In collaboration with Sarah Sinnett, Ph.D. to develop miRARE, our goal was to design a regulated construct that allowed us to control MECP2 expression to potentially avoid adverse events that are typically seen with unregulated gene therapies.”

The FDA defines a rare pediatric disease as a serious or life-threatening disease in which the disease manifestations primarily affect individuals aged from birth to 18 years. Pediatric diseases recognized as “rare” affect under 200,000 people in the U.S. The Rare Pediatric Disease Priority Review Voucher Program is intended to address the challenges that drug companies face when developing treatments for these unique patient populations. Under this program, companies are

Read More →

Dentist Fortitude Valley, Precision Dental, Offers General and Cosmetic Dentistry Solutions in a Caring and Friendly Environment in QLD – Press Release

Dentist Fortitude Valley, Precision Dental, Offers General and Cosmetic Dentistry Solutions in a Caring and Friendly Environment in QLD

Fortitude Valley, QLD – Not every dentist is the same. There are those that will only be concerned about providing treatment while there are others that will go above and beyond in ensuring that patients are feeling comfortable. Precision Dental is a modern dental practice that is based at the heart of Brisbane servicing Fortitude Valley and is committed to high-quality dental care. The practice provides both general and cosmetic dental treatment for the whole family.

“Our ultra-modern practice is conveniently located in HQ Towers which offer free onsite parking for the duration of treatment. Emergency appointments are available throughout the day and Saturday appointments can be arranged. We are equipped with the latest generation of equipment and pride ourselves in providing thorough dental treatment that is tailored to individual needs and goals.” Said Dr Billy Choi, the spokesperson for the clinic, regarding their unrivalled services.

The dental practice was founded on three key principles including honesty, patient comfort, and quality. Every member of the staff will ensure that patients are comfortable right from the moment they walk in their office. The clinic uses the latest generation of quiet equipment to ensure that dental visits are enjoyable. Some of the tools that can be found in the treatment room to make patients relax include:


Parents can rest easy knowing that the clinic offers children’s dental emergency treatments. Children have high energy and are always going to be susceptible to dental emergencies. The dentists have knowledge in dealing with such unexpected events and will ensure that children are not experiencing discomfort a minute longer. The practice applies advanced skills in dentistry and state-of-the-art equipment to overcome dental emergencies.

The clinic also aims at being the leading cosmetic dentistry treatment provider in Fortitude Valley, one smile at a time. The treatment options are tailored to meet the individual needs of the patient. A good dentist Fortitude Valley is one that will start by assessing the individual needs of the patient before coming up with a course of action and this is exactly what you get when you reach out to Precision Dental. Getting a smile makeover will help in maintaining a youthful appearance and also boosts the self-confidence of a person. Patients can enjoy all of these benefits by booking a dental appointment with Precision Dental at their own convenient time.

The clinic also believes in providing education to patients because good dental care requires a holistic approach. The clinic believes that a dentist should be a partner when it comes to the wellbeing of the teeth, gums, and mouth. Precision Dental provides patients with both basic and advanced information so that they’re establishing a consistent and reliable oral care routine. It is also easy for patients to book an appointment when they visit their website.

Precision Dental is located at S13, HQ South Tower, 520 Wickham St, Fortitude Valley, QLD 4006. For enquiries regarding the top-rated dentist Fortitude Valley and the services offered, contact their team by calling (07) 3852 1160

Read More →

Med students on how COVID pushed them into action, highlighted health care inequities

It was on a Saturday in mid-March when Abby Schiff, then a third-year medical student at Harvard working through surgery clinical rotations, found out she wouldn’t be going back to the hospital.



a group of people on a sidewalk: Medical student Francis Wright (top left) during a mask drive early on in the pandemic with his classmates (clockwise) India Perez-Urbano, Kara Lau, Lane Epps, Ninad Bhat, Laeesha Cornejo and Hunter Jackson, the last of whom came up with the idea.


© Courtesy Francis Wright
Medical student Francis Wright (top left) during a mask drive early on in the pandemic with his classmates (clockwise) India Perez-Urbano, Kara Lau, Lane Epps, Ninad Bhat, Laeesha Cornejo and Hunter Jackson, the last of whom came up with the idea.

She had worked the day before, but with the coronavirus threat growing quickly, Schiff, like thousands of other medical students across the country, was sidelined when the Association of American Medical Colleges issued a temporary suspension of clinical rotations in hopes of protecting students and patients, and conserving personal protective equipment (PPE).

She didn’t sit around waiting, though. As nurses came out of retirement and medical school professors pressed pause on teaching to answer the call to action on the front lines, Schiff also got to work. Within hours, she and a group of other students started building a crash course on COVID-19 for medical professionals.

“At the time, a lot of Harvard medical students were talking about what was going on, and [it] felt like we suddenly had a lot of time on our hands,” Schiff told ABC News. “There was this crisis going on. How can we best contribute?”



a woman standing in front of a book shelf: Abby Schiff, a fourth-year medical student at Harvard Medical School, helped to create the school's COVID-19 curriculum and still keeps it updated on a regular basis.


© ABC News
Abby Schiff, a fourth-year medical student at Harvard Medical School, helped to create the school’s COVID-19 curriculum and still keeps it updated on a regular basis.

In less than a week, 70 of Schiff’s colleagues, including students and faculty, had put together a comprehensive, open-source COVID-19 curriculum.

“So we had about 80 pages of content — all referenced, all freely available — including things like thought questions, quiz questions… helpful information about how to put on masks and PPE, run ventilators,” she said. “And then also an explainer about basic epidemiological terms, about sort of the basics of virology and immunology and the clinical manifestations that were known at the time.”

Seven months later, the curriculum is still being updated with the latest science on a regular basis. Today, it includes modules on mental health, global health and communication, all meant to “dispel misinformation and myths,” said Schiff.



graphical user interface, application: Fourth-year Harvard medical student Abby Schiff (second from top left) attends a video meeting with her fellow students to discuss updates to their school's open-source COVID-19 curriculum.


© Courtesy Abby Schiff
Fourth-year Harvard medical student Abby Schiff (second from top left) attends a video meeting with her fellow students to discuss updates to their school’s open-source COVID-19 curriculum.

As co-chair for outreach, she said her role is to reach out to students and groups that are using the curriculum to get an idea of their needs and how they can best be met, as well as recruiting students to contribute. The curriculum has already been implemented in 32 medical schools across the country as either an elective or mandatory course, and it has been translated into 27 languages and used in at least 110 countries, Schiff said.

“It’s had a really wide reach, including in areas where

Read More →

Summa Equity Acquires Sengenics to Advance Precision Medicine Through Proteomics

Summa Equity, the purpose-driven private equity firm that invests to solve global challenges, has acquired a majority stake in Sengenics, a functional proteomics company with a proprietary technology called KREX that enables researchers to vastly improve the understanding of the human proteome and immune system. Proteomics, i.e. the large-scale study of proteins, is one of the most important areas for gaining insights into human biology and disease, as protein expressions, structures and functions are critical in reflecting states of health.

Sengenics was first founded in 2008 and went on to commercialise the KREX technology that was originally developed from a joint collaboration between the University of Cambridge and the University of Oxford. The company’s patented KREX technology enables researchers to address both the function and folding structure of proteins using one technology that allows for large numbers of proteins to be studied simultaneously, with high sensitivity and specificity. The combination of these capabilities makes KREX unique. The technology is relevant for a broad range of applications in research and throughout the value chain for drugs, vaccines and diagnostics. Sengenics is currently mainly focused on autoantibody detection for applications in autoimmune diseases, oncology and infectious diseases, including COVID-19. The company recently launched a unique high-throughput, multi-antigen, multi-domain and fully quantitative COVID-19 test, leveraging the KREX technology.

Sengenics has grown rapidly in recent years and established customer relationships with top global pharmaceutical companies, and leading research and academic institutions around the world. The company currently has commercial partnerships with 9 out of the top 10 pharmaceutical companies to co-develop complementary and companion diagnostic tests for autoimmune and cancer immunotherapy drugs. Sengenics is based in Europe and South-East Asia.

“Sengenics’ proprietary technology unlocks tremendous potential for researchers around the world to further their understanding of biology and disease,” says Tommi Unkuri, Partner at Summa Equity. “We are proud to partner with the company and support its journey, as it looks to expand its position in the market and grow its business. We look forward to supporting the Sengenics team in our shared ambition to invest to drive product development, global expansion and accelerated adoption.”

Summa Equity invests in companies that address global challenges, while managing environmental, social, and governance (ESG) factors, with the aim of increasing returns and reducing risk. It was the first company to align its investments with the UN Sustainable Development Goals. The investment in Sengenics is aligned with the firm’s Changing Demographics theme and supports the SDG Target #3: “Ensure healthy lives and promote well-being for all at all ages”, by enabling improved diagnosis, treatment and patient outcomes across a number of disease areas.

“We are excited to welcome Summa Equity as a major strategic investor and shareholder in Sengenics. Their extensive capabilities and alignment with our vision of changing the future of medicine through immune-proteomics is a very strong strategic fit. Summa also has a great deal of relevant knowledge and experience to be a value-added owner for us given its ownership of Olink Proteomics. This

Read More →

Porter dentist offers free oral cancer screenings for firefighters

As a thank you to local first responders, Porter Family Dentistry is offering free oral cancer screenings to firefighters in Montgomery County for the next several weeks.

The screenings will be held on Fridays when the office is usually closed so that firefighters don’t have to wait.

In 2016, the National Institute for Occupational Safety and Health published a multi-year study of cancer rates in firefighters, and the findings showed that firefighters had a higher number of cancer diagnoses and cancer-related deaths than the general U.S. population. Among the cancers found in the sample of nearly 30,000 firefighters, those most often found were digestive, oral, respiratory, and urinary cancers.

In recent months, firefighters across the country have been traveling to areas, like California, that their help is needed. Dr. Mustafa Yamani of Porter Family Dentistry went to school in California and has fond memories of the nature and beauty of the state.

“It’s such a beautiful place, it’s really sad reading all of the stuff in the news that’s going on there,” Yamani said. “From all around the country they (the firefighters) come together and they provide this service. It’s just amazing what they’re doing and I really appreciate that. I just want to do something for them.”


The generous act of the firefighters inspired him to give back, and since oral cancer screenings are a service his office already offers he decided to give them to firefighters for free.

While this is the first year that the dental office has offered free screenings, Yamani and his wife Sabrina, who is the office manager, plan on making it an annual thing. The trials of 2020 also helped them decide to give back.

“Things seem to be going from bad to worse, to even worse, and it just doesn’t seem to be stopping for our first responders,” Sabrina said. “They’re just being hit with things one after the other.”

Sabrina started by reaching out to fire departments in the east past of Montgomery County to let them know about the opportunity and the response was immediate and positive. Already, the dental office has screenings set up with local firefighters.

Because firefighters are at a higher risk of developing cancer, many departments take an aggressive approach to screenings and check-ups. Early detection is vital. Such is the approach of the East Montgomery County Fire Department where firefighters undergo a National Fire Protection Agency physicals annually.

“It’s huge to us,” Eran Denzler, captain and PIO with the department, said of being able to get the oral screenings for free. “It’s a great show of appreciation for what we do and the risks that we take. Every day we go and put our lives on the line for the community, and for them to give back and worry about our safety is something we’re not used to but it’s much appreciated.”

The department averages around one to two structure fires a week,

Read More →

Beyond Celiac Chosen by 9 Meters Biopharma as Exclusive Patient Organization to Recruit for First-Ever Phase 3 Clinical Trial

Premier Patient Recruiter for Celiac Disease Research, Beyond Celiac Taps Extensive Network to Advance Study

Go Beyond Celiac, an online patient database launched in 2017, allows its thousands of users to participate in research by sharing their celiac disease stories and experiences and learn how to become involved in research studies such as the Phase 3
Go Beyond Celiac, an online patient database launched in 2017, allows its thousands of users to participate in research by sharing their celiac disease stories and experiences and learn how to become involved in research studies such as the Phase 3
Go Beyond Celiac, an online patient database launched in 2017, allows its thousands of users to participate in research by sharing their celiac disease stories and experiences and learn how to become involved in research studies such as the Phase 3

Philadelphia, PA, Oct. 14, 2020 (GLOBE NEWSWIRE) — Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, today announced it has been chosen by 9 Meters Biopharma, Inc. (Nasdaq: NMTR) as the exclusive patient organization to recruit for the first-ever Phase 3-stage clinical trial therapeutic for treatment of celiac disease. Beyond Celiac will use its unrivaled connection to the celiac disease community and its powerful online patient database to recruit participants for the study of larazotide acetate, which aims to address leaky gut in celiac disease.

“We really listen to our community’s wants and needs. Because of our extensive connection to the people and commitment to connecting researchers with our community, Beyond Celiac has become the partner of choice for leading biotechnology and pharmaceutical companies such as 9 Meters,” said Beyond Celiac CEO Alice Bast. “This is the furthest a celiac disease clinical trial has gone, and it’s an exciting opportunity for our organization to play a vital role in fulfilling its promise.”

9 Meters Biopharma is evaluating larazotide acetate for celiac disease patients who continue to experience gastrointestinal symptoms while following a gluten-free diet. Designed to tighten junctions between intestinal cells, larazotide acetate would act like shoelaces to help restore leaky junctions to a normal state and would be used in addition to the gluten-free diet. It is being tested at more than 100 clinical sites, with a goal of 525 study participants. Results are expected by the end of 2021.

By partnering with Beyond Celiac for recruitment, 9 Meters Biopharma now has access to the power of Go Beyond Celiac, a secure online patient database with thousands of users who share their celiac disease stories and experiences with researchers and seek to become involved in studies.

“Our conservative estimate is that our celiac disease program is at least two years ahead of everyone else’s,” said John Temperato, president and CEO of 9 Meters Biopharma. “Beyond Celiac is going to help us across the finish line in developing the effective treatments that celiac patients deserve.”

Celiac disease is a serious genetic autoimmune disorder that affects an estimated 1 in 133 Americans, more than half of whom are still undiagnosed. The disease causes damage to the small intestine, resulting in debilitating symptoms, and if left untreated, can lead to serious long-term health problems including infertility and some types of cancer.

 

About Beyond Celiac

Founded in 2003,

Read More →